Literature DB >> 16557542

Intrahepatic cholestasis of pregnancy as an indicator of liver and biliary diseases: a population-based study.

Anne Ropponen1, Reijo Sund, Seija Riikonen, Olavi Ylikorkala, Kristiina Aittomäki.   

Abstract

Intrahepatic cholestasis of pregnancy (ICP) is a liver disorder, thought to be specific for pregnancy and to spontaneously resolve after delivery. Increased rates of gallstone formation and hepatitis C have previously been associated with ICP. However, there are no longitudinal studies to determine its significance as an indicator of subsequent liver or biliary diseases. In this retrospective cohort study with cases and controls we assessed the risk of liver and biliary diseases in 21,008 women, 10,504 with a history of ICP during the years 1972-2000 (cases) and 10,504 with a normal pregnancy (controls). Cases and controls were matched for age, time of delivery, and place of delivery. The diagnoses of liver and biliary disease were traced from the Finnish Hospital Discharge Register with an almost 100% coverage. Several liver and biliary diseases were found to have a significantly higher incidence in patients with ICP than in controls. The rate ratio for hepatitis C was 3.5 (CI 1.6-7.6; P < .001), for nonalcoholic liver cirrhosis 8.2 (CI 1.9-35.5; P < .05), for gallstones and cholecystitis 3.7 (CI 3.2-4.2; P < .001) and for nonalcoholic pancreatitis 3.2 (CI 1.7-5.7; P < .001). In conclusion, there is an association of ICP with several liver and biliary diseases. Some patients with ICP are at risk of the subsequent development of cirrhosis and other severe chronic diseases. Contrary to what has been previously thought, follow-up may need to be considered for these patients.

Entities:  

Mesh:

Year:  2006        PMID: 16557542     DOI: 10.1002/hep.21111

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  34 in total

Review 1.  [The specific dermatoses of pregnancy].

Authors:  C M Ambros-Rudolph
Journal:  Hautarzt       Date:  2010-12       Impact factor: 0.751

Review 2.  Intrahepatic cholestasis of pregnancy-current achievements and unsolved problems.

Authors:  Jurate Kondrackiene; Limas Kupcinskas
Journal:  World J Gastroenterol       Date:  2008-10-14       Impact factor: 5.742

Review 3.  Intrahepatic cholestasis of pregnancy.

Authors:  Victoria Geenes; Catherine Williamson
Journal:  World J Gastroenterol       Date:  2009-05-07       Impact factor: 5.742

4.  Liver: Links between hepatobiliary diseases in and beyond pregnancy.

Authors:  Lucy C Chappell; Catherine Williamson
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-05-28       Impact factor: 46.802

Review 5.  Pregnancy-related liver disorders.

Authors:  Ashish Goel; Kapil D Jamwal; Anup Ramachandran; Kunissery A Balasubramanian; Chundamannil E Eapen
Journal:  J Clin Exp Hepatol       Date:  2013-03-16

6.  Maternal buprenorphine treatment and fetal neurobehavioral development.

Authors:  Lauren M Jansson; Martha Velez; Krystle McConnell; Nancy Spencer; Michelle Tuten; Hendree E Jones; Van L King; Neeraj Gandotra; Lorraine A Milio; Kristin Voegtline; Janet A DiPietro
Journal:  Am J Obstet Gynecol       Date:  2017-02-07       Impact factor: 8.661

Review 7.  Immunological basis in the pathogenesis of intrahepatic cholestasis of pregnancy.

Authors:  Spencer P Larson; Oormila Kovilam; Devendra K Agrawal
Journal:  Expert Rev Clin Immunol       Date:  2015-10-15       Impact factor: 4.473

Review 8.  Review of a challenging clinical issue: Intrahepatic cholestasis of pregnancy.

Authors:  Sebiha Ozkan; Yasin Ceylan; Orhan Veli Ozkan; Sule Yildirim
Journal:  World J Gastroenterol       Date:  2015-06-21       Impact factor: 5.742

9.  Good pregnancy outcome despite intrahepatic cholestasis.

Authors:  Kaisa Turunen; Markku Sumanen; Riitta-Liisa Haukilahti; Pertti Kirkinen; Kari Mattila
Journal:  Scand J Prim Health Care       Date:  2010-06       Impact factor: 2.581

Review 10.  Liver diseases in pregnancy: diseases unique to pregnancy.

Authors:  Khulood T Ahmed; Ashraf A Almashhrawi; Rubayat N Rahman; Ghassan M Hammoud; Jamal A Ibdah
Journal:  World J Gastroenterol       Date:  2013-11-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.